Flora Growth Corp.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Daniel Reis-Faria
- Full Time Employees
- 64
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 365 Bay Street Toronto ON Canada M5H 2V1
- IPO Date
- May 11, 2021
- CIK
- 0001790169
- Website
- floragrowth.com
- Similar Companies
- Business
- Flora Growth Corp. Flora Growth Corp. (NASDAQ: FLGC), together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals; it cultivates, processes, and supplies medicinal-grade cannabis flower, cannabis-derived medical and wellness products including food and beverage, nutraceuticals, cannabidiol (CBD)-derived products such as gummies, topicals, tinctures, and vape products, cannabis consumption accessories, personal care, and wellness items; and it manufactures and distributes pharmaceutical goods and medical cannabis products to treat health indications including cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants, sold under brands including JustCBD, Vessel, Phatebo, and Peak USA. Flora Growth maintains one of the largest outdoor cultivation facilities at its Cosechemos subsidiary in Colombia, supports an EU-GMP compliant extraction facility, and leverages Phatebo GmbH for pharmaceutical distribution in Germany with an extensive network across Hilzingen; it generates revenue from the United States, Germany, Australia, the United Kingdom, Colombia, the Czech Republic, and Slovakia, targeting wholesale buyers, consumer packaged goods customers, pharmacies, and pharmaceutical markets. Founded in 2019 and headquartered in Fort Lauderdale, Florida, with prior roots in Toronto, Ontario, Canada, and additional operations in Carlsbad, California, the company recently executed a transformative $401 million private investment in public equity offering in September 2025 led by DeFi Dev Corp., Hexstone Capital, Carlsberg SE Asia PTE Ltd, and others including Dao5 and Abstract Ventures, comprising $35 million cash and $366 million in-kind digital assets primarily 0G tokens to initiate an AI Zero Gravity ($0G) coin treasury strategy, alongside purchases of 0G tokens, appointment of BitGo as custodian, a planned rebrand to ZeroStack while retaining the FLGC ticker, and leadership changes including Michael Heinrich as Executive Chairman and Daniel Reis-Faria as CEO.
Flora Growth (NASDAQ:FLGC) and Veru (NASDAQ:VERU) Financial Review
Flora Growth Corp. Announces Withdrawal of Proposed Public Offering
Flora Growth Corp. Announces Proposed Underwritten Public Offering
Flora Growth Corp. Announces Name Change to ZeroStack Corp., Furthering Its Strategy as an AI-Focused Asset Management Company
Flora Growth Announces Results of 2025 Special Meeting of Shareholders
Why Did Flora Growth Corp (FLGC) Surge 6% In After-Hours Trading?
Flora Growth Corp. (FLGC) Reports Q3 Loss, Misses Revenue Estimates
Flora Growth Corp. Announces Second Purchase of 0G, the Fuel of the 0G Decentralized AI Network
Flora Growth Corp. Appoints BitGo as Custodian for $0G Treasury
Flora Growth Corp. Announces First Purchase of 0G, the Fuel of the 0G Decentralized AI Network
Flora Growth Corp. (FLGC) Announces $401 Million Funding with a $22.88 Million Strategic Investment from Defi Development Corp. (DFDV) to Initiate Groundbreaking AI Zero Gravity ($0G) Coin Treasury Strategy
Flora Regains Compliance with NASDAQ Minimum Bid Requirement
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
Flora Growth Corp. Announces 1-for-39 Share Consolidation
Flora Growth Announces Results of 2025 Annual and Special Meeting of Shareholders
Flora Growth Corp. Reports 2024 Financial Results
Flora Announces Appointment of Patrick Moloney as Head of Product Development for Vessel
Clifford Starke's Holdings in Flora Growth Corp.
Flora Growth Corp. Announces Closing of $3.6 Million Registered Direct Offering
Flora Growth Corp. Announces Pricing of $3.6 Million Registered Direct Offering